B Lymphocytes Are a Predictive Marker of Eribulin Response and Overall Survival in Locally Advanced or Metastatic Breast Cancer: A Multicenter, Two-Cohort, Non-Randomized, Open-Lab... von Tashireva, Liubov A., Popova, Nataliya O., Kalinchuk, Anna Yu, Goldberg, Viktor E., Kovalenko, Elena I., Artamonova, Elena V., Manikhas, Aleksey G., Ponomarenko, Dmitriy M., Levchenko, Nataliya V., Rossokha, Elena I., Krasilnikova, Svetlana Yu, Zafirova, Marina A., Choynzonov, Evgeniy L., Perelmuter, Vladimir M.

Volltext

nextMONARCH Phase 2 randomized clinical trial: overall survival analysis of abemaciclib monotherapy or in combination with tamoxifen in patients with endocrine-refractory HR + , HE... von Hamilton, Erika, Cortes, Javier, Ozyilkan, Ozgur, Chen, Shin-Cheh, Petrakova, Katarina, Manikhas, Aleksey, Jerusalem, Guy, Hegg, Roberto, Huober, Jens, Zhang, Wei, Chen, Yanyun, Martin, Miguel

Volltext

nextMONARCH: Abemaciclib Monotherapy or Combined With Tamoxifen for Metastatic Breast Cancer von Hamilton, Erika, Cortes, Javier, Ozyilkan, Ozgur, Chen, Shin-Cheh, Petrakova, Katarina, Manikhas, Aleksey, Jerusalem, Guy, Hegg, Roberto, Huober, Jens, Chapman, Sonya C., Lu, Yi, Hardebeck, Molly C., Bear, Melissa M., Johnston, Erica L., Martin, Miguel

Volltext